CG
EW icon

Colony Group’s Edwards Lifesciences EW Stock Holding History

Colony Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$928K Sell
13,398
-724
-5% -$58.2K 0.01% 440
2023
Q2 		$1.33M Buy
14,122
+71
+0.5% +$6.17K 0.02% 395
2023
Q1 		$1.16M Sell
14,051
-712
-5% -$56K 0.02% 415
2022
Q4 		$1.1M Sell
14,763
-302
-2% -$23.3K 0.02% 466
2022
Q3 		$1.25M Buy
15,065
+6,929
+85% +$667K 0.02% 399
2022
Q2 		$774K Sell
8,136
-6,596
-45% -$683K 0.01% 514
2022
Q1 		$1.73M Sell
14,732
-670
-4% -$75.2K 0.03% 377
2021
Q4 		$2M Sell
15,402
-325
-2% -$37.9K 0.04% 325
2021
Q3 		$1.78M Hold
15,727
– – 0.03% 329
2021
Q2 		$1.63M Buy
15,727
+594
+4% +$56K 0.03% 323
2021
Q1 		$1.27M Sell
15,133
-97
-0.6% -$8.2K 0.03% 357
2020
Q4 		$1.39M Buy
15,230
+323
+2% +$26.8K 0.03% 318
2020
Q3 		$1.19M Hold
14,907
– – 0.03% 335
2020
Q2 		$1.03M Buy
14,907
+3,150
+27% +$224K 0.03% 339
2020
Q1 		$739K Sell
11,757
-2,127
-15% -$153K 0.02% 388
2019
Q4 		$1.08M Buy
13,884
+1,350
+11% +$105K 0.03% 393
2019
Q3 		$919K Buy
12,534
+1,254
+11% +$88.1K 0.03% 386
2019
Q2 		$695K Sell
11,280
-135,642
-92% -$8.2M 0.02% 438
2019
Q1 		$9.37M Sell
146,922
-1,242
-0.8% -$70.9K 0.39% 72
2018
Q4 		$7.57M Sell
148,164
-174
-0.1% -$8.8K 0.37% 82
2018
Q3 		$8.61M Sell
148,338
-4,122
-3% -$202K 0.43% 63
2018
Q2 		$7.4M Buy
152,460
+46,131
+43% +$2.15M 0.39% 71
2018
Q1 		$4.95M Buy
+106,329
New +$4.62M 0.27% 92
2014
Q4 		– Sell
-348
Closed -$6K – 784
2014
Q3 		$6K Buy
348
+318
+1,060% +$5.02K ﹤0.01% 680
2014
Q2 		$0 Buy
+30
New +$407 ﹤0.01% 785

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Colony Group's EW Position: Q3 2023 in Review

Colony Group reduced its Edwards Lifesciences (EW) stake by 5.1% in Q3 2023, selling an estimated $58.2K and leaving 13,398 shares worth $928K. The position accounts for 0.01% of the portfolio, ranked #440.

Colony Group first reported a position in EW in Q2 2014 and has held it in 25 quarters since. The position peaked at $9.37M in Q1 2019. 1,220 funds tracked by Wall St. Rank hold EW as of Q3 2023.

  • Colony Group held 13,398 shares of Edwards Lifesciences worth $928K as of Q3 2023.
  • Colony Group sold 724 Edwards Lifesciences shares in Q3 2023, an estimated $58.2K.
  • Edwards Lifesciences made up 0.01% of Colony Group's portfolio in Q3 2023, its #440 holding.
  • Colony Group first reported a position in Edwards Lifesciences in Q2 2014 and has held it in 25 quarters since.
  • Colony Group's Edwards Lifesciences position peaked at $9.37M in Q1 2019.
  • 1,220 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.

Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.